Edwards Lifesciences Performance

Edwards Lifesciences Corporation -- USA Stock  

USD 114.22  0.09  0.0787%

On a scale of 0 to 100 Edwards Lifesciences holds performance score of 13. The firm shows Beta (market volatility) of 1.467 which denotes to the fact that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Edwards Lifesciences will likely underperform.. Although it is vital to follow to Edwards Lifesciences historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By reviewing Edwards Lifesciences technical indicators you can presently evaluate if the expected return of 0.331% will be sustainable into the future. Please utilizes Edwards Lifesciences Information Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to make a quick decision on weather Edwards Lifesciences price patterns will revert.
Investment Horizon     30 Days    Login   to change

Edwards Lifesciences Relative Risk vs. Return Landscape

If you would invest  10,716  in Edwards Lifesciences Corporation on November 18, 2017 and sell it today you would earn a total of  706  from holding Edwards Lifesciences Corporation or generate 6.59% return on investment over 30 days. Edwards Lifesciences Corporation is generating 0.331% of daily returns and assumes 1.5595% volatility on return distribution over the 30 days horizon. Put differently, 14% of equity instruments are less risky than the company on the bases of their historical return distribution and some 94% of equities are expected to be superior in generating returns on investments over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Allowing for the 30-days total investment horizon, Edwards Lifesciences Corporation is expected to generate 3.39 times more return on investment than the market. However, the company is 3.39 times more volatile than its market benchmark. It trades about 0.21 of its potential returns per unit of risk. The DOW is currently generating roughly 0.55 per unit of risk.

Operating Margin

Edwards Lifesciences Operating Margin
Based on recorded statements Edwards Lifesciences Corporation has Operating Margin of 29.97%. This is 191.12% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Operating Margin for all stocks is 374.7% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.

Edwards Lifesciences Daily Price Distribution

The median price of Edwards Lifesciences for the period between Sat, Nov 18, 2017 and Mon, Dec 18, 2017 is 113.8 with a coefficient of variation of 3.61. The daily time series for the period is distributed with a sample standard deviation of 4.07, arithmetic mean of 112.75, and mean deviation of 3.46. The Stock received some media coverage during the period.
13 

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corporation are ranked lower than 13 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Edwards Lifesciences Sharpe Ratio = 0.2122
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsEW
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 1.56
  actual daily
 
 86 %
of total potential
  

Expected Return

 0.33
  actual daily
 
 6 %
of total potential
  

Risk-Adjusted Return

 0.21
  actual daily
 
 13 %
of total potential
  
Based on monthly moving average Edwards Lifesciences is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.